|
| |
GliomaA glioma is a type of primary central nervous system tumor that arises from glial cells. The most common site of involvement of gliomas is the brain, but gliomas can also affect the spinal cord or any other part of the CNS, such as the optic nerves. (From the Wikpedia article Glioma.) Download PDF containing detailed information.
Recent Publications on Glioma: |  |
IDH1 and IDH2 hotspot mutations are not found in canine glioma.
BACKGROUND AND PURPOSE: ADC measurements have been shown to have an... | 31st October, 2009
| The Preston Robert Tisch Brain Tumor Center and The Pediatric Brain Tumor
| Int J Cancer. 2009 Oct 29.
DOI Direct Link |
Gamma interferon-mediated superinduction of B7-H1 in PTEN-deficient glioblastoma: a paradoxical mechanism of immune evasion.
B7 homolog 1 (B7-H1) is a recently discovered immunoresistance protein... | 31st October, 2009
| Department of Neurological Surgery, University of California at San
| Neuroreport. 2009 Oct 28.
DOI Direct Link |
Intracellular reactions affecting 2-amino-4-([(11)C]methylthio)butyric acid ([(11)C]methionine) response to carbon ion radiotherapy in C10 glioma cells.
PURPOSE: The response of 2-amino-4-([(14)C]methylthio)butyric acid... | 31st October, 2009
| Graduate School of Pharmaceutical Sciences, Chiba University, Chiba,
| Nucl Med Biol. 2009 Nov;36(8):985-91. Epub 2009 Oct 3.
DOI Direct Link |
Direct detection and quantification of abasic sites for in vivo studies of DNA damage and repair.
Use of chemotherapeutic agents to induce cytotoxic DNA damage and... | 31st October, 2009
| Division of Radiopharmaceutical Science, Case Center for Imaging Research,
| Nucl Med Biol. 2009 Nov;36(8):975-83. Epub 2009 Oct 3.
DOI Direct Link |
Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination.
We have successfully treated over two hundred high-grade glioma (HGG)... | 31st October, 2009
| Department of Neurosurgery, University Hospital Leuven, Leuven, Belgium;
| J Immunol Methods. 2009 Oct 26.
DOI Direct Link |
→View more research publications. |
Press Releases About Glioma:
|
 |
| NexGenix Pharmaceuticals Awarded Phase I Grant from the National Institute of Neurological Disorders and Stroke (NINDS) Small Business Innovation Research Program (SBIR) for the Development of Novel Small Molecule Hsp90 Therapeutics to Treat Glioma |
22nd October, 2009 |
NexGenix Pharmaceuticals Holdings, Inc. |
NEW YORK, Oct. 22 /PRNewswire/ -- NexGenix Pharmaceuticals Holdings, Inc. a privately-held biotechnology company with a portfolio of novel targeted therapies for oncology and neurodegenerative
|
| Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting |
26th May, 2009 |
Ascenta Therapeutics |
MALVERN, Pa., May 26 /PRNewswire/ -- Ascenta Therapeutics announced today that eleven presentations or publications on pre-clinical and clinical studies of AT-101, an oral, pan-Bcl-2 inhibitor, in
|
| Surveyed Oncologists Indicate that Avastin has Advantages over Temodar/Temodal in Increasing Overall Survival of High-Grade Glioma |
9th March, 2009 |
Decision Resources |
A Drug That Improves Survival, When Added to Temodar/Temodal, Would Earn a 65 Percent Patient Share in the U.S. and a 30 Percent Patient Share in Europe in Newly Diagnosed Glioblastoma Multiforme,
|
| Prayers From Maria - Children's Glioma Cancer Foundation Hosts Sunflower Soiree |
3rd February, 2009 |
Prayers From Maria |
CLEVELAND, Feb. 3 /PRNewswire/ -- Prayers From Maria - Children's Glioma
Cancer Foundation will be hosting its second annual Sunflower Soiree.
WHAT: The Sunflower Soiree
WHEN: 7 p
|
| Avastin and Other Emerging Agents Will Drive the Glioma Drug Market to More Than $1.8 Billion in 2017 |
8th December, 2008 |
Decision Resources |
Generic Erosion Will Reduce Sales of Schering-Plough's Temodar/Temodal, the Current Market Leader, According to a New Report from Decision Resources
WALTHAM, Mass., Dec. 8 /PRNewswire/ --
|
Companies working in the area of Glioma from Bioportfolio's Biocorporate database : | |
| Company Name | |
Xenova Group Limited, a fully-owned subsidiary of Celtic Pharma Development plc, is a UK-based biopharmaceutical company focused on the development of novel drugs to treat cancer and addiction with a...
www.KSBIOMEDIX.COM/ View full profile
| |
Barcelona Spine Center is a clinic specialising in minimally invasive spinal surgery and neurosurgery.
Our specialists have over 15 years of experience and offer safe and effective...
www.bcn-sc.com/ View full profile
| |
BioPortfolio Ltd. offers e-mail and postal lists for Glioma scientists - we have details of around 2676 individuals working on Glioma .
This page has been viewed 515 times
Recent Search Terms used to find this page: glioblastoma children 2009 | sunflower soiree | temodal microdialysis | glioma news 2009 | about glioma | Glioma Stem Cells: Better Flat Than Round | Glioma Stem Cells: Better Flat Than Round | about glioma | glioma in 2009 | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Glioma across BioPortfolio, or for Glioma Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
